Table 2.
Results Achieved in Study Groups and P‐Values
| Values | Active Hepatitis B | Inactive Hepatitis B | Control group | F | P |
|---|---|---|---|---|---|
| Paroxonase (U/l) | 104.7±58.9 | 138.4±67.6 | 184.6±9.2a | 13.4 | 0.000 |
| Arylesterase (kU/l) | 140.6±20.7a | 164.2±19.2a | 161.6±28.9a | 26.7 | 0.000 |
| ALT (IU/ml) | 92.8±72.0a | 23.7±11.8 | 23.2±11.5 | 35.1 | 0.000 |
| HDL (mg/dl) | 39.0±9.7 | 43.2±10.0 | 48.0±6.1a | 10.3 | 0.000 |
| LDL (mg/dl) | 100.6±23.1 | 94.9±18.0 | 96.1±18.6 | 0.8 | 0.437 |
ALT, alanine aminotransferase; AST, aspartate aminotransferase; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein.
a
aGroup which created a difference.